Clinical outcomes of atypical extra-esophageal reflux symptoms following laparoscopic antireflux surgery
- PMID: 21717265
- DOI: 10.1007/s00464-011-1806-y
Clinical outcomes of atypical extra-esophageal reflux symptoms following laparoscopic antireflux surgery
Abstract
Introduction: While it is well established that antireflux surgery is effective in relieving typical gastroesophageal reflux disease (GERD) symptoms such as heartburn and regurgitation, it is currently unclear whether atypical symptoms (cough, hoarseness, wheeze) foreshadow a less satisfactory outcome following laparoscopic antireflux surgery (LARS). The purpose of this study is to critically analyze the clinical outcomes of atypical symptoms in patients undergoing LARS.
Methods: Patients scheduled for LARS for GERD were prospectively enrolled over a 7-year period; all subjects underwent preoperative high-resolution manometry (HRM) and had evidence of GERD on ambulatory pH study. Cough, wheeze, and hoarseness were considered atypical symptoms. During preoperative and postoperative examinations, patients completed detailed foregut symptomatology questionnaires, using both 5-point Likert and 10-point visual analog scales (VAS) to document typical as well as atypical symptoms. Atypical symptom burden was calculated as a sum of VAS for the three atypical symptoms, termed the atypical score (ATS). HRM patterns were grouped into normal, spastic, and hypomotile. Statistical significance (p < 0.05) was determined using paired t-test, and analysis of variance with post hoc least significant difference (LSD).
Results: One hundred thirteen patients (age 49 ± 1.26 years, range 20-84 years, M:F 47:66) with mean follow-up of 28 ± 2.31 months (range 1-92 months) fulfilled inclusion criteria, having mean modified DeMeester score of 45.5 ± 2.78. Heartburn was noted in 84.1%, while atypical symptoms of some degree were reported by 92.0% (104 patients). Heartburn improved from a preoperative score of 7.1 ± 0.54 to 0.9 ± 0.24 after LARS, and ATS improved from 8.9 ± 0.71 to 2.2 ± 0.42. Significant improvements were noted for all atypical symptoms analyzed (p < 0.0001 for each). Improvement in atypical symptoms was least in the presence of hypomotility features on HRM (21.7% improvement), compared with normal motility (72.4%) and spastic features (83.9%). Preoperative atypical score (p < 0.0001) and esophageal hypomotility (p = 0.04) demonstrated a linear relationship with postoperative atypical score.
Conclusions: In an unselected cohort of patients undergoing LARS, atypical GERD symptoms improved as significantly as typical symptoms. Symptom improvement was significantly lower in the presence of esophageal hypomotility and with higher symptomatic state. Therefore, patients with severe atypical symptoms or hypomotile esophagus may not achieve the same clinical satisfaction from LARS.
Similar articles
-
Value of preoperative esophageal function studies before laparoscopic antireflux surgery.Surg Endosc. 2011 Sep;25(9):2943-9. doi: 10.1007/s00464-011-1646-9. Epub 2011 Mar 18. Surg Endosc. 2011. PMID: 21424193
-
Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder.Surg Endosc. 2006 Dec;20(12):1824-30. doi: 10.1007/s00464-005-0329-9. Surg Endosc. 2006. PMID: 17063301
-
Esophageal hypermotility: cause or effect?Dis Esophagus. 2016 Jul;29(5):497-502. doi: 10.1111/dote.12367. Epub 2015 Apr 20. Dis Esophagus. 2016. PMID: 25893778
-
Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy.Surg Endosc. 2003 Aug;17(8):1200-5. doi: 10.1007/s00464-002-8910-y. Epub 2003 May 13. Surg Endosc. 2003. PMID: 12739117 Review.
-
The evolution and long-term results of laparoscopic antireflux surgery for the treatment of gastroesophageal reflux disease.JSLS. 2010 Jul-Sep;14(3):332-41. doi: 10.4293/108680810X12924466007007. JSLS. 2010. PMID: 21333184 Free PMC article. Review.
Cited by
-
Atypical symptoms are related to typical symptoms rather than histologic and endoscopic esophagitis.J Neurogastroenterol Motil. 2012 Jul;18(3):233-5. doi: 10.5056/jnm.2012.18.3.233. Epub 2012 Jul 10. J Neurogastroenterol Motil. 2012. PMID: 22837869 Free PMC article. No abstract available.
-
Treatment implications of high-resolution manometry findings: options for patients with esophageal dysmotility.Curr Treat Options Gastroenterol. 2014 Mar;12(1):34-48. doi: 10.1007/s11938-013-0003-6. Curr Treat Options Gastroenterol. 2014. PMID: 24430335
-
24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.Surg Endosc. 2015 Jul;29(7):1700-8. doi: 10.1007/s00464-014-3867-1. Epub 2014 Nov 15. Surg Endosc. 2015. PMID: 25398192
-
Outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease in non-responders to proton pump inhibitors.J Gastrointest Surg. 2014 Sep;18(9):1557-62. doi: 10.1007/s11605-014-2584-3. Epub 2014 Jul 2. J Gastrointest Surg. 2014. PMID: 24985244
-
[Importance of functional endoscopy for diagnostics of extraesophageal reflux : relationship of Belafsky's reflux symptom index and functional endoscopic data].HNO. 2014 Nov;62(11):806-12. doi: 10.1007/s00106-014-2912-7. HNO. 2014. PMID: 25231697 Clinical Trial. German.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical